Close Menu
  • Home
  • Tech&AI
    • Claude AI
    • Chatgpt
    • Gemini
    • Grok
  • News
    • Canada
    • United States
    • Australia
    • Europe
    • Asia
    • Africa
    • Politics
  • Classifieds Toronto
  • Service Canada
    • Immigration and citizenship
    • Renew your passport online in Canada
    • Service Canada
    • Service Ontario
      • Service Toronto
    • Service Alberta
      • Service Edmonton
      • Service Calgary
    • British Columbia
      • Victoria
      • Vancouver
    • Manitoba
      • Winnipeg
    • Quebec
      • Quebec City
      • Montreal
    • Newfoundland and Labrador
      • St. John’s
    • New Brunswick
      • Fredericton
      • Saint John
    • Nova Scotia
      • Halifax
    • Prince Edward Island
      • Charlottetown
    • Saskatchewan
      • Regina
      • Saskatoon
  • Education&Jobs
    • Universities in Canada
    • Toronto public schools
    • Free English lessons
    • Language Assessment and Referral Services
    • Toronto Public Library
    • Jobs in Canada
    • Job-Manpower
  • Home&Lifestyle
    • Buy or Rent a house
      • Realtor
      • Apartments for Rent in Toronto
    • Health
      • General hospital locations
      • Find a doctor or nurse
      • Health Canada
      • Toronto Health & Wellness
      • LifeLabs-Canada’s largest lab
    • Travel
      • Travel and tourism
      • Visit Toronto
      • Air Canada
    • Entertainment
    • Sports
  • Business
    • Finance
      • TD Bank
      • RBC Bank
      • CIBC Bank
      • BMO Bank
      • Scotia Bank
      • National Bank
    • Investing
      • Invest Canada
    • Companies
      • Ontario Business Registry
      • Trademarks
    • Stocks
      • Toronto stock Exchange
      • The New York Stock Exchange
      • Nasdaq: Stock Market
      • Yahoo Finances
    • Markets
      • Exhibition place
      • Metro Toronto Convention Centre
      • THE INTERNATIONAL CENTRE
      • Traders Forum Show
    • Crypto
    • Economy
  • Store
    • Make grocery shopping simple
    • Shopping Centres & Department Stores
    • COSTCO
    • Canadian Tire
    • Home Depot
    • Walmart
    • Foodbanks & Charities
  • Free TV
    • Free TV
    • Watch Free Movies Online with Plex
    • Korean TV
  • Free Games
    • Free Game1
    • Free game2
    • Europe
What's Hot

After 7 years in Canada, young student faces deportation

November 17, 2026

Schumer, Van Hollen battle for 28 votes in historic Senate Democratic leadership showdown

November 17, 2026

AFL Draft 2026: Top West Australian prospect Heath Mellody on West Coast links, idolising Nick Daicos

November 17, 2026
Facebook X (Twitter) Instagram
Tuesday, November 17
The Smart Times Toronto
Subscribe
  • Home
  • Tech&AI
    • Claude AI
    • Chatgpt
    • Gemini
    • Grok
  • News
    1. Canada
    2. United States
    3. Australia
    4. Europe
    5. Asia
    6. Africa
    7. Politics
    8. View All

    After 7 years in Canada, young student faces deportation

    November 17, 2026

    Religious symbols ban for Quebec schoolchildren? Conservatives leave door open

    November 17, 2026

    Nova Scotia officials warn toxic drugs increasingly mixed with veterinary sedative – Halifax

    November 17, 2026

    Proposed Saint John data centre could generate tax windfall, critics unconvinced – New Brunswick

    November 17, 2026

    Schumer, Van Hollen battle for 28 votes in historic Senate Democratic leadership showdown

    November 17, 2026

    As Trump Goes to China, A.I. Tensions Surge Amid Spying and Safety Fears

    November 17, 2026

    US basketball player arrested in Nigeria over 75 pounds of cannabis

    November 17, 2026

    Victim Advocates Sue Newsom Over Attempt to Empty California’s Death Row

    November 17, 2026

    AFL Draft 2026: Top West Australian prospect Heath Mellody on West Coast links, idolising Nick Daicos

    November 17, 2026

    Claims Aussie teens being ‘pickpocketed’ by country’s biggest employers as Senate probes superannuation overhaul

    November 17, 2026

    Bodies of mother, young son pulled from Craigieburn lake in Melbourne’s north

    November 17, 2026

    Dramatic videos show bullet paths from killer cop's gun

    November 17, 2026

    Why is a South China Sea Code of Conduct still unfinished after decades of talks?

    November 17, 2026

    Trump arrives in Manila for Quad talks ahead of China visit

    November 17, 2026

    Trump to kick off Asia trip with Quad talks in Manila ahead of China visit

    November 17, 2026

    Odds rise of Trump-Kim meeting on APEC sidelines, analysts say

    November 17, 2026

    Trump’s Culture War, Amid Setbacks, Will Soon Face a Hostile Congress

    November 17, 2026

    Democrat proposes $1,700 Iran war refund checks for American families

    November 17, 2026

    White House “tiger team” formed to prevent another nationwide ground stop

    November 17, 2026

    The Blue Wave Lifted Democrats. But Not All Progressives Rose as High.

    November 17, 2026

    After 7 years in Canada, young student faces deportation

    November 17, 2026

    Schumer, Van Hollen battle for 28 votes in historic Senate Democratic leadership showdown

    November 17, 2026

    AFL Draft 2026: Top West Australian prospect Heath Mellody on West Coast links, idolising Nick Daicos

    November 17, 2026

    Why is a South China Sea Code of Conduct still unfinished after decades of talks?

    November 17, 2026
  • Classifieds Toronto
  • Service Canada
    • Immigration and citizenship
    • Renew your passport online in Canada
    • Service Canada
    • Service Ontario
      • Service Toronto
    • Service Alberta
      • Service Edmonton
      • Service Calgary
    • British Columbia
      • Victoria
      • Vancouver
    • Manitoba
      • Winnipeg
    • Quebec
      • Quebec City
      • Montreal
    • Newfoundland and Labrador
      • St. John’s
    • New Brunswick
      • Fredericton
      • Saint John
    • Nova Scotia
      • Halifax
    • Prince Edward Island
      • Charlottetown
    • Saskatchewan
      • Regina
      • Saskatoon
  • Education&Jobs
    • Universities in Canada
    • Toronto public schools
    • Free English lessons
    • Language Assessment and Referral Services
    • Toronto Public Library
    • Jobs in Canada
    • Job-Manpower
  • Home&Lifestyle
    • Buy or Rent a house
      • Realtor
      • Apartments for Rent in Toronto
    • Health
      • General hospital locations
      • Find a doctor or nurse
      • Health Canada
      • Toronto Health & Wellness
      • LifeLabs-Canada’s largest lab
    • Travel
      • Travel and tourism
      • Visit Toronto
      • Air Canada
    • Entertainment
    • Sports
  • Business
    • Finance
      • TD Bank
      • RBC Bank
      • CIBC Bank
      • BMO Bank
      • Scotia Bank
      • National Bank
    • Investing
      • Invest Canada
    • Companies
      • Ontario Business Registry
      • Trademarks
    • Stocks
      • Toronto stock Exchange
      • The New York Stock Exchange
      • Nasdaq: Stock Market
      • Yahoo Finances
    • Markets
      • Exhibition place
      • Metro Toronto Convention Centre
      • THE INTERNATIONAL CENTRE
      • Traders Forum Show
    • Crypto
    • Economy
  • Store
    • Make grocery shopping simple
    • Shopping Centres & Department Stores
    • COSTCO
    • Canadian Tire
    • Home Depot
    • Walmart
    • Foodbanks & Charities
  • Free TV
    • Free TV
    • Watch Free Movies Online with Plex
    • Korean TV
  • Free Games
    • Free Game1
    • Free game2
    • Europe
The Smart Times Toronto
Home»Health
Health

Fearing Chinese Rivals, U.S. Biotech Adopts a New Norm: Share Nothing

Press RoomBy Press RoomNovember 17, 2026No Comments8 Mins Read
Facebook Twitter Pinterest LinkedIn Reddit Telegram WhatsApp
Share
Facebook Twitter LinkedIn Pinterest Reddit Telegram WhatsApp

It used to be that companies and scientists with ideas for new drugs couldn’t wait to announce their discoveries at meetings, in preprints and on their websites.

That is changing.

Researchers at the biotechnology firm Alnylam Pharmaceuticals have an unwritten policy: Do not reveal early-stage studies or discuss unpublished data, according to its founding chief executive, Dr. Christoph Westphal.

Jacob Becraft of Strand Therapeutics delays filing for patents to keep his company’s discoveries secret. And he is careful about disclosing his company’s intellectual property and confidential material, even to investors.

Alexis Borisy, a co-founder of Curie.Bio, which helps early-stage biotechs, says he tells scientists to “go dark” — don’t publish, don’t present posters at meetings, don’t even go to meetings.

The reason for this guarded stance? Fears that Chinese companies will seize on the biotechs’ discoveries and quickly beat them to market with the U.S. firms’ own inventions or with slightly altered versions that dilute market exclusivity.

“This is the world we’re in now,” Mr. Borisy said. Meetings are where scientists discuss new ideas. Publication is the lifeblood of science. But now, being too open too soon has become too risky, he and others said.

The concern is not only the risk of a significant economic hit if the United States cedes most of its biotech industry to China. It’s also a fear of direct effects on patients — the possibility that China might use access to drugs as a cudgel, experts said.

China has used its control of other resources that way, like its meting out of rare-earth minerals, a tactic used in trade wars with the United States. If China controls access to a valuable drug, like a cancer treatment for instance, it could use it for political leverage, warned the National Security Commission on Emerging Biotechnology, an advisory group, in a report to Congress.

The Chinese Communist Party heavily subsidizes its biotech industry and says biotech is its highest priority, on par with artificial intelligence. Its five-year plan calls for China to make at least 25 percent of the world’s “first in class innovative medicines” over the next five years.

“With the trajectory they are on, I think they are being conservative,” said John Crowley, president and chief executive of BIO, an advocacy group. With lavish support, Chinese companies have been discovering more and more promising drugs. Mr. Crowley added that today about 30 to 35 percent of innovative medicines under development are of Chinese origin.

The United States, meanwhile, has a funding problem, said Cyriac Roeding, an investor. Small biotech companies depend on investors, which leaves them at the mercy of boom-and-bust cycles during the 10 to 12 years it takes to bring a drug to market.

The National Security Commission on Emerging Biotechnology made that same point in its report, writing that the nation needs a “‘private-public’ partnership for biotechnology driven by industry in collaboration with government.”

Multiple biotech executives, investors and those who study the industry, say their fears — that China is not playing fair, and that American biotech will lag in the future — are well-founded.

A recent paper in JAMA outlined China’s rise: In 2015, 48 percent of early-stage drug development was in the United States and 8 percent was in China. In 2024, 37 percent was in the United States and 32 percent was in China.

“My prediction is they will leapfrog us in biotechnology in the not too distant future,” said Dr. Steven Paul, a partner in the health care venture firm Third Rock Ventures.

‘Disingenuous Competition’

Mr. Borisy cautioned that “disingenuous competition” was prompting American biotechs’ tactic of “going dark”: In one form of it, he said, Chinese investigators use A.I. agents that scour presentations at every scientific conference and rifle through every patent.

“The moment anything is out there, it is tracked,” Mr. Borisy said, adding that if there is a new idea, companies in China will seize on it. Many will get nowhere but, he said, if even a couple of these companies succeed, they can get a clinical trial going much faster than the U.S. inventors can.

Chinese companies, Mr. Crowley noted, can complete clinical trials “three times quicker than we can and at half the cost.”

Dr. Becraft said he and others had grown leery of representatives of Chinese companies at meetings who say they are investors and dangle promises of millions of dollars. These “investors,” he said, have sometimes turned out to be scouting for a company’s discoveries and do not in fact have money to offer. “I’ve stopped talking to them,” Dr. Becraft said.

At other times, Chinese competitors employ a technique that biotech firms call fast-follower/design-around: A U.S. company invents a drug and patents it; a Chinese company changes its design slightly to get around the U.S. patent.

That is what Revolution Medicines alleges happened to it. Its scientists worked for years to develop a drug for people with a gene mutation that drives nearly all pancreatic cancers. They patented the stunningly effective design, but then, seemingly out of nowhere, Chinese scientists licensed a nearly identical drug to a U.S.-based company, Erasca. Revolution Medicines said its trade secrets were “misappropriated.” Erasca denied the allegations.

Lisa Roessler says her company, Amyris, has been plagued by what she describes as outright data theft. Amyris engineers specialized yeast whose products can be used, for example, in vaccines and cosmetics. Its 15 commercial products took years and millions of dollars to develop. But recently, at trade shows, Chinese companies have been advertising the same products — presented with the same data, including the same number of people in clinical trials, the same results and other such impossibilities.

“One of the things we’ve seen is descriptions of our products, not just word for word but the data in brochures is literally our data, in the same format,” Ms. Roessler said.

China has denied previous claims that it steals trade secrets. “The Chinese government will not, in whatever form, engage in commercial theft or encourage or support such attempts by anyone,” said President Xi Jinping of China in a public speech in Seattle in 2015.

Fear of reprisal

Stories of research appropriation abound, although few companies want to talk publicly about the details of what happened to them.

There’s a reason for that, said Melissa Roberts Chapman, president of KC Biohub. “If you were to make an allegation and later want to bring a drug to market in China, you might have trouble.”

Ms. Roessler added that most American companies depend on China to manufacture their drugs and conduct early-stage clinical trials. Those who criticize China can be, and have been, punished by denial of access.

Dr. Becraft said that after he began speaking out there was a five- to 10-fold increase in cyberattacks on his company’s computers and his private accounts. A U.S. government official told him it would be best if he did not travel to China.

The industrywide fear of reprisal was particularly apparent in May, when the U.S. International Trade Commission held a hearing in Washington on China’s threat to biotechs. The group had invited 297 individuals and groups to testify. But, Ms. Chapman said, when it came to the hearing, “only eight were in the room.”

Not everyone thinks the dangers are as real as they’re made out to be, however.

Peter Kolchinsky, an investor and managing partner of RA Capital Management, says that misguided fears about China are actually driving flawed policy proposals. “China hawks,” as he called them, often cite the rare-earth example, saying that just as China cornered the rare-earth market and used it for political advantage, it could do the same thing with drugs.

He disagreed. “Drugs are not commodities,” said Mr. Kolchinsky, whose more than 200 companies are mostly in the United States. “The equivalent of the rare-earth situation would be if the U.S. relied on China to manufacture all drugs.”

But, he added, that is not happening, and, with careful planning, it need not happen for individual drugs.

Mr. Kolchinsky said the solution to the China threat was not to restrict collaborations with or investment in Chinese firms. That can harm rather than help American companies, he said, because U. S. investors and companies will not know what’s going on in China. That will make it hard to know when a U.S. company’s product is the best.

What the ultimate path forward may be is unclear, however, when every avenue to presenting or sharing ideas could lead to theft. And few think legal actions will solve the bigger problem.

Today’s situation “is not an accident,” said Caitlin Frazer, executive director of the National Security Commission on Emerging Biotechnology. Instead, it is the product of 20 or 25 years of a deliberate strategy by the Chinese government, with a doubling down on the effort in the latest update to the Chinese government’s five-year plan.

Last year, the commission published a report on how to save the nation’s biotech industry. It made 49 recommendations and said the United States needed to provide incentives for research, speed clinical trials and reduce investment risk.

Mr. Crowley of Bio said it was not too late for U.S. biotech. “Unlike in chips, where we totally lost it, we still have the lead in biotech,” he said.

But, he said, there is no time to waste: “We need to be sure we don’t wake up and see biotech wither.”

Share. Facebook Twitter Pinterest LinkedIn Reddit Telegram WhatsApp
Press Room
  • Website

Keep Reading

Measles Is Sickening More Pregnant Women and Newborns, Alarming Doctors

An Intriguing Approach to Slow Alzheimer’s Shows Mixed Results

John H. Powers III to Lead NIAID Amid Turmoil

This Cancer Kills Children in a Year. Research Has Been Stalled for a Year.

Finally, a Vaccine for Cancer

American Global Health Aid Isn’t Dead. It’s Changing.

Add A Comment
Leave A Reply Cancel Reply

THJ MAILBOX SERVICES
GOLDBAY TELECOM INC.
Facebook X (Twitter) Pinterest Vimeo WhatsApp TikTok Instagram

News

  • World News
  • United States
  • Canada
  • Europe
  • Australia
  • Asia
  • Africa

Business

  • Stocks
  • Economy
  • Finance
  • Investing
  • Markets
  • Companies
  • Crypto

SITE LINKS

  • Newsletter
  • Community
  • Work with us
  • Press Room
  • Media
  • Cookie Policy
  • About Us

Subscribe to Updates

Get the latest politics, business, sports, lifestyle, and many more news directly to your inbox.

© 2026 The Smart Times Toronto. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Press Release
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.